

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.54980688 |
| 2 | kynurenine metabolic process (GO:0070189) | 5.42669025 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 5.27964851 |
| 4 | sarcomere organization (GO:0045214) | 5.14210270 |
| 5 | myofibril assembly (GO:0030239) | 5.07657826 |
| 6 | opioid receptor signaling pathway (GO:0038003) | 5.04813863 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.93759534 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.93759534 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.93759534 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 4.70695125 |
| 11 | indolalkylamine metabolic process (GO:0006586) | 4.67860704 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.63891723 |
| 13 | muscle filament sliding (GO:0030049) | 4.59827859 |
| 14 | actin-myosin filament sliding (GO:0033275) | 4.59827859 |
| 15 | cardiac myofibril assembly (GO:0055003) | 4.57678794 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.39808146 |
| 17 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.30778753 |
| 18 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.27191937 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.25609169 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.15110122 |
| 21 | actin-mediated cell contraction (GO:0070252) | 4.02314401 |
| 22 | regulation of sarcomere organization (GO:0060297) | 3.97707537 |
| 23 | heart process (GO:0003015) | 3.95730224 |
| 24 | heart contraction (GO:0060047) | 3.95730224 |
| 25 | skeletal muscle contraction (GO:0003009) | 3.92552688 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 3.82685104 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.79641237 |
| 28 | daunorubicin metabolic process (GO:0044597) | 3.75268555 |
| 29 | polyketide metabolic process (GO:0030638) | 3.75268555 |
| 30 | doxorubicin metabolic process (GO:0044598) | 3.75268555 |
| 31 | primary amino compound metabolic process (GO:1901160) | 3.71740844 |
| 32 | cellular response to ATP (GO:0071318) | 3.70712598 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 3.68793884 |
| 34 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.68432415 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 3.64790313 |
| 36 | cardiac muscle contraction (GO:0060048) | 3.63948988 |
| 37 | indole-containing compound metabolic process (GO:0042430) | 3.63468402 |
| 38 | superoxide anion generation (GO:0042554) | 3.62346776 |
| 39 | striated muscle contraction (GO:0006941) | 3.61340863 |
| 40 | serotonin metabolic process (GO:0042428) | 3.49688561 |
| 41 | adult heart development (GO:0007512) | 3.47893563 |
| 42 | response to pheromone (GO:0019236) | 3.47556626 |
| 43 | striated muscle hypertrophy (GO:0014897) | 3.45119302 |
| 44 | skeletal muscle adaptation (GO:0043501) | 3.40742083 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40431868 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 3.40431868 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40431868 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40431868 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40431868 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.40431868 |
| 51 | regulation of striated muscle contraction (GO:0006942) | 3.39158423 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 3.36489304 |
| 53 | muscle hypertrophy (GO:0014896) | 3.35257990 |
| 54 | amine catabolic process (GO:0009310) | 3.32394535 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 3.32394535 |
| 56 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.29468998 |
| 57 | cellular response to zinc ion (GO:0071294) | 3.28714216 |
| 58 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.27318645 |
| 59 | detection of light stimulus involved in visual perception (GO:0050908) | 3.27318645 |
| 60 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.26801671 |
| 61 | actomyosin structure organization (GO:0031032) | 3.26148324 |
| 62 | synaptic transmission, cholinergic (GO:0007271) | 3.24098483 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23660596 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21977029 |
| 65 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21977029 |
| 66 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21977029 |
| 67 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.21778119 |
| 68 | gamma-aminobutyric acid transport (GO:0015812) | 3.20402802 |
| 69 | striated muscle atrophy (GO:0014891) | 3.20326964 |
| 70 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.20059352 |
| 71 | muscle atrophy (GO:0014889) | 3.19983398 |
| 72 | positive regulation of fatty acid oxidation (GO:0046321) | 3.19113540 |
| 73 | platelet dense granule organization (GO:0060155) | 3.17706379 |
| 74 | otic vesicle formation (GO:0030916) | 3.16801145 |
| 75 | fucose catabolic process (GO:0019317) | 3.15945650 |
| 76 | L-fucose metabolic process (GO:0042354) | 3.15945650 |
| 77 | L-fucose catabolic process (GO:0042355) | 3.15945650 |
| 78 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.15406075 |
| 79 | ketone body metabolic process (GO:1902224) | 3.12844884 |
| 80 | kidney morphogenesis (GO:0060993) | 3.09429448 |
| 81 | regulation of activation of Janus kinase activity (GO:0010533) | 3.08745535 |
| 82 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.07544486 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04778702 |
| 84 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.03470084 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02033251 |
| 86 | hindbrain development (GO:0030902) | 3.01123163 |
| 87 | protein complex biogenesis (GO:0070271) | 3.00586104 |
| 88 | microglial cell activation (GO:0001774) | 3.00113169 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99962689 |
| 90 | negative regulation of muscle hypertrophy (GO:0014741) | 2.98951042 |
| 91 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.98386851 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97512450 |
| 93 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.96193154 |
| 94 | response to muscle activity (GO:0014850) | 2.96182883 |
| 95 | cardiac muscle cell development (GO:0055013) | 2.95316532 |
| 96 | response to host immune response (GO:0052572) | 2.94470653 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94470653 |
| 98 | regulation of membrane repolarization (GO:0060306) | 2.92558558 |
| 99 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.91299961 |
| 100 | detection of calcium ion (GO:0005513) | 2.90904764 |
| 101 | cornea development in camera-type eye (GO:0061303) | 2.90697414 |
| 102 | neuronal action potential (GO:0019228) | 2.90267627 |
| 103 | regulation of cardiac muscle contraction (GO:0055117) | 2.90159087 |
| 104 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.89857666 |
| 105 | cardiac cell development (GO:0055006) | 2.89125680 |
| 106 | cardiac chamber formation (GO:0003207) | 2.89048107 |
| 107 | muscle tissue morphogenesis (GO:0060415) | 2.87588024 |
| 108 | response to inactivity (GO:0014854) | 2.87512163 |
| 109 | positive regulation of fatty acid transport (GO:2000193) | 2.86921610 |
| 110 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85814999 |
| 111 | aromatic amino acid family catabolic process (GO:0009074) | 2.84902926 |
| 112 | actin filament-based movement (GO:0030048) | 2.83680444 |
| 113 | striated muscle adaptation (GO:0014888) | 2.81701655 |
| 114 | benzene-containing compound metabolic process (GO:0042537) | 2.80956179 |
| 115 | regulation of antigen processing and presentation (GO:0002577) | 2.79410090 |
| 116 | positive regulation of heart rate (GO:0010460) | 2.78477294 |
| 117 | cytidine metabolic process (GO:0046087) | 2.78110115 |
| 118 | cytidine catabolic process (GO:0006216) | 2.78110115 |
| 119 | cytidine deamination (GO:0009972) | 2.78110115 |
| 120 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.78048942 |
| 121 | dendritic cell chemotaxis (GO:0002407) | 2.76147322 |
| 122 | spinal cord motor neuron differentiation (GO:0021522) | 2.76000768 |
| 123 | somite development (GO:0061053) | 2.75208152 |
| 124 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.75138077 |
| 125 | NAD biosynthetic process (GO:0009435) | 2.74698347 |
| 126 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.74500135 |
| 127 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.74486287 |
| 128 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.74411074 |
| 129 | energy homeostasis (GO:0097009) | 2.73984279 |
| 130 | regulation of sequestering of triglyceride (GO:0010889) | 2.73768767 |
| 131 | positive regulation of defense response to virus by host (GO:0002230) | 2.73020132 |
| 132 | desmosome organization (GO:0002934) | 2.72105903 |
| 133 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.71693810 |
| 134 | cardiac muscle cell action potential (GO:0086001) | 2.69680990 |
| 135 | peristalsis (GO:0030432) | 2.69625608 |
| 136 | muscle adaptation (GO:0043500) | 2.67895473 |
| 137 | response to peptidoglycan (GO:0032494) | 2.67798913 |
| 138 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.67417658 |
| 139 | muscle hypertrophy in response to stress (GO:0003299) | 2.67417658 |
| 140 | cardiac muscle adaptation (GO:0014887) | 2.67417658 |
| 141 | dendritic cell migration (GO:0036336) | 2.67249416 |
| 142 | cardiac ventricle formation (GO:0003211) | 2.65919845 |
| 143 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.65282057 |
| 144 | aromatic amino acid family metabolic process (GO:0009072) | 2.64447773 |
| 145 | adrenergic receptor signaling pathway (GO:0071875) | 2.63497574 |
| 146 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.62447370 |
| 147 | positive regulation of action potential (GO:0045760) | 2.61821841 |
| 148 | adenosine metabolic process (GO:0046085) | 2.61708375 |
| 149 | respiratory chain complex IV assembly (GO:0008535) | 2.60164808 |
| 150 | cAMP catabolic process (GO:0006198) | 2.59764116 |
| 151 | relaxation of cardiac muscle (GO:0055119) | 2.59522704 |
| 152 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.58549792 |
| 153 | positive regulation of heat generation (GO:0031652) | 2.58472108 |
| 154 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.57905862 |
| 155 | cardiac conduction (GO:0061337) | 2.56461264 |
| 156 | positive regulation of vascular permeability (GO:0043117) | 2.56311196 |
| 157 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.55153221 |
| 158 | behavioral response to ethanol (GO:0048149) | 2.52464941 |
| 159 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.52054611 |
| 160 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.51692322 |
| 161 | protein localization to cytoskeleton (GO:0044380) | 2.51556299 |
| 162 | sulfation (GO:0051923) | 2.49361690 |
| 163 | nephron epithelium morphogenesis (GO:0072088) | 2.48155190 |
| 164 | nephron tubule morphogenesis (GO:0072078) | 2.48155190 |
| 165 | neural tube formation (GO:0001841) | 2.48125831 |
| 166 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.47885804 |
| 167 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.47218240 |
| 168 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.46030692 |
| 169 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.45663825 |
| 170 | reflex (GO:0060004) | 2.45576339 |
| 171 | regulation of action potential (GO:0098900) | 2.45232247 |
| 172 | regulation of memory T cell differentiation (GO:0043380) | 2.44713702 |
| 173 | transepithelial transport (GO:0070633) | 2.43659724 |
| 174 | regulation of glucokinase activity (GO:0033131) | 2.42541107 |
| 175 | regulation of hexokinase activity (GO:1903299) | 2.42541107 |
| 176 | neurotransmitter metabolic process (GO:0042133) | 2.39930230 |
| 177 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.39289011 |
| 178 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.39172706 |
| 179 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.37876533 |
| 180 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.37876533 |
| 181 | auditory receptor cell stereocilium organization (GO:0060088) | 2.36561518 |
| 182 | dopamine transport (GO:0015872) | 2.35950668 |
| 183 | neurotransmitter catabolic process (GO:0042135) | 2.35679234 |
| 184 | piRNA metabolic process (GO:0034587) | 2.34716442 |
| 185 | molting cycle (GO:0042303) | 2.33930491 |
| 186 | hair cycle (GO:0042633) | 2.33930491 |
| 187 | embryonic epithelial tube formation (GO:0001838) | 2.33700140 |
| 188 | regulation of hippo signaling (GO:0035330) | 2.33624164 |
| 189 | inner ear receptor stereocilium organization (GO:0060122) | 2.31942844 |
| 190 | protein localization to microtubule (GO:0035372) | 2.31372734 |
| 191 | negative regulation of telomere maintenance (GO:0032205) | 2.30031489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22196857 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.48360163 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.13761329 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11996163 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.03162341 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.97357403 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53805527 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36894419 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.36733963 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33300774 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27014693 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25447528 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.10227377 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10176960 |
| 15 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.06763300 |
| 16 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.00361775 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99767904 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97488367 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.95719053 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93828511 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.90710145 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.89237536 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85559951 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84146972 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82159744 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78858019 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78845851 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76796593 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.76032905 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.73716495 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73637797 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.64195615 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63746228 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61171443 |
| 35 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.60993497 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.59426177 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58640229 |
| 38 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.58157653 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56978039 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55653172 |
| 41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.54058193 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53503423 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52427142 |
| 44 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.51974610 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50816937 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50582298 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.49891847 |
| 48 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.49033299 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45713273 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.45178187 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.45178187 |
| 52 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.44117286 |
| 53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43390629 |
| 54 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.43301203 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41005381 |
| 56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40701802 |
| 57 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.38574917 |
| 58 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38038054 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38038054 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37936669 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37936669 |
| 62 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.37280006 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36296712 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34755405 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34039821 |
| 66 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.33640752 |
| 67 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32583062 |
| 68 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.32437847 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30610795 |
| 70 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30201570 |
| 71 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.30095308 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29440572 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29121485 |
| 74 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.28906423 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27855751 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24946772 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24801398 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24224774 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24052739 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23462715 |
| 81 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23451064 |
| 82 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23027484 |
| 83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22463048 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21847484 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21094544 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20862555 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20779449 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20566295 |
| 89 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20377636 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20352312 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18888925 |
| 92 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18753199 |
| 93 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18753199 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17863983 |
| 95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17532236 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17045123 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16845647 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 1.16156672 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16108664 |
| 100 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.15843515 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14978041 |
| 102 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.14704463 |
| 103 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14244308 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14139946 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13996992 |
| 106 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13744225 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13573643 |
| 108 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.13233985 |
| 109 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.13080179 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12691510 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12689727 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12323278 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11966805 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11594952 |
| 115 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10281491 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09068750 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08842284 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08594411 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08567424 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08567424 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07965420 |
| 122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07449631 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06783314 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05938554 |
| 125 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05634981 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04923171 |
| 127 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04798307 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04539164 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04165491 |
| 130 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.03945488 |
| 131 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02916447 |
| 132 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02622408 |
| 133 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02541267 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02242992 |
| 135 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02176239 |
| 136 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02156577 |
| 137 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02118459 |
| 138 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01388328 |
| 139 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01345696 |
| 140 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01013005 |
| 141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00104639 |
| 142 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99934323 |
| 143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99877426 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99463912 |
| 145 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99255908 |
| 146 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99086772 |
| 147 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98440191 |
| 148 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98205688 |
| 149 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.97977627 |
| 150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97718581 |
| 151 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.97539593 |
| 152 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95417495 |
| 153 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.95347800 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94774363 |
| 155 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94308752 |
| 156 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.93732314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.99698216 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.91929446 |
| 3 | MP0000751_myopathy | 3.73941931 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.59334386 |
| 5 | MP0003195_calcinosis | 3.59326938 |
| 6 | MP0000749_muscle_degeneration | 3.51754546 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.38192038 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.83382973 |
| 9 | MP0003011_delayed_dark_adaptation | 2.82176303 |
| 10 | MP0004510_myositis | 2.80574437 |
| 11 | MP0003828_pulmonary_edema | 2.47819826 |
| 12 | MP0005670_abnormal_white_adipose | 2.47297917 |
| 13 | MP0000566_synostosis | 2.44597361 |
| 14 | MP0005330_cardiomyopathy | 2.42760443 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.41192603 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.25147799 |
| 17 | MP0004885_abnormal_endolymph | 2.21654236 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.21339807 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14562138 |
| 20 | MP0005620_abnormal_muscle_contractility | 2.13373696 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.06053990 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.05257791 |
| 23 | MP0000383_abnormal_hair_follicle | 2.03951252 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 2.03043834 |
| 25 | MP0000750_abnormal_muscle_regeneration | 2.02197218 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 2.02122461 |
| 27 | MP0004484_altered_response_of | 1.94491692 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.93998076 |
| 29 | MP0002102_abnormal_ear_morphology | 1.93509670 |
| 30 | MP0004043_abnormal_pH_regulation | 1.90695695 |
| 31 | MP0004087_abnormal_muscle_fiber | 1.83432772 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.80907163 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.74841557 |
| 34 | MP0008872_abnormal_physiological_respon | 1.74516400 |
| 35 | MP0000427_abnormal_hair_cycle | 1.73543128 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.73185343 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.71721011 |
| 38 | MP0005385_cardiovascular_system_phenoty | 1.71721011 |
| 39 | MP0002938_white_spotting | 1.71694743 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.70756902 |
| 41 | MP0004142_abnormal_muscle_tone | 1.68745409 |
| 42 | MP0005369_muscle_phenotype | 1.66759118 |
| 43 | MP0001188_hyperpigmentation | 1.64698098 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.58462719 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.57800679 |
| 46 | MP0002736_abnormal_nociception_after | 1.57558902 |
| 47 | MP0004130_abnormal_muscle_cell | 1.55277271 |
| 48 | MP0005387_immune_system_phenotype | 1.54167763 |
| 49 | MP0001790_abnormal_immune_system | 1.54167763 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.53811240 |
| 51 | MP0005671_abnormal_response_to | 1.52600539 |
| 52 | MP0002127_abnormal_cardiovascular_syste | 1.50986227 |
| 53 | MP0004085_abnormal_heartbeat | 1.50348043 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.47899161 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.47744308 |
| 56 | MP0003941_abnormal_skin_development | 1.46820475 |
| 57 | MP0005253_abnormal_eye_physiology | 1.46505720 |
| 58 | MP0009785_altered_susceptibility_to | 1.45935436 |
| 59 | MP0004742_abnormal_vestibular_system | 1.41307265 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.39625872 |
| 61 | MP0001853_heart_inflammation | 1.37900175 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.36780918 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.33871704 |
| 64 | MP0009745_abnormal_behavioral_response | 1.32563534 |
| 65 | MP0000343_altered_response_to | 1.32237701 |
| 66 | MP0002419_abnormal_innate_immunity | 1.30215696 |
| 67 | MP0006138_congestive_heart_failure | 1.27565447 |
| 68 | MP0003136_yellow_coat_color | 1.26672027 |
| 69 | MP0005409_darkened_coat_color | 1.21275377 |
| 70 | MP0002269_muscular_atrophy | 1.20659929 |
| 71 | MP0005171_absent_coat_pigmentation | 1.20307838 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.19511956 |
| 73 | MP0003724_increased_susceptibility_to | 1.18922140 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.17303730 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.14656492 |
| 76 | MP0002272_abnormal_nervous_system | 1.14050757 |
| 77 | MP0001529_abnormal_vocalization | 1.14004495 |
| 78 | MP0009046_muscle_twitch | 1.12135511 |
| 79 | MP0004924_abnormal_behavior | 1.10102666 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.10102666 |
| 81 | MP0002332_abnormal_exercise_endurance | 1.10023827 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.09454618 |
| 83 | MP0005448_abnormal_energy_balance | 1.08168422 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.07635715 |
| 85 | MP0002452_abnormal_antigen_presenting | 1.06536503 |
| 86 | MP0004381_abnormal_hair_follicle | 1.05323122 |
| 87 | MP0005332_abnormal_amino_acid | 1.04455622 |
| 88 | MP0001324_abnormal_eye_pigmentation | 1.03074503 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 1.02860887 |
| 90 | MP0001800_abnormal_humoral_immune | 1.02722090 |
| 91 | MP0005025_abnormal_response_to | 1.02647106 |
| 92 | MP0002723_abnormal_immune_serum | 1.02176782 |
| 93 | MP0008260_abnormal_autophagy | 1.01559724 |
| 94 | MP0008877_abnormal_DNA_methylation | 1.01255933 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 1.00338422 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.99861539 |
| 97 | MP0000026_abnormal_inner_ear | 0.98600725 |
| 98 | MP0002254_reproductive_system_inflammat | 0.95412951 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.94699718 |
| 100 | MP0003436_decreased_susceptibility_to | 0.93949188 |
| 101 | MP0002163_abnormal_gland_morphology | 0.92952033 |
| 102 | MP0000372_irregular_coat_pigmentation | 0.92857061 |
| 103 | MP0008995_early_reproductive_senescence | 0.92356908 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.91975397 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.91955574 |
| 106 | MP0001819_abnormal_immune_cell | 0.90470571 |
| 107 | MP0005266_abnormal_metabolism | 0.90235739 |
| 108 | MP0001346_abnormal_lacrimal_gland | 0.90115489 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.89762724 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.89548678 |
| 111 | MP0002064_seizures | 0.89458028 |
| 112 | MP0001486_abnormal_startle_reflex | 0.89365499 |
| 113 | MP0009764_decreased_sensitivity_to | 0.88480798 |
| 114 | MP0002638_abnormal_pupillary_reflex | 0.88185148 |
| 115 | MP0002420_abnormal_adaptive_immunity | 0.88030560 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.87542511 |
| 117 | MP0002098_abnormal_vibrissa_morphology | 0.86193233 |
| 118 | MP0005187_abnormal_penis_morphology | 0.86002164 |
| 119 | MP0005389_reproductive_system_phenotype | 0.85754720 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.84736629 |
| 121 | MP0005165_increased_susceptibility_to | 0.84531997 |
| 122 | MP0002822_catalepsy | 0.84293962 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.84116489 |
| 124 | MP0004133_heterotaxia | 0.82233591 |
| 125 | MP0005310_abnormal_salivary_gland | 0.81762094 |
| 126 | MP0001919_abnormal_reproductive_system | 0.81527026 |
| 127 | MP0003878_abnormal_ear_physiology | 0.81373439 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.81373439 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.81349749 |
| 130 | MP0002572_abnormal_emotion/affect_behav | 0.81075686 |
| 131 | MP0005195_abnormal_posterior_eye | 0.80992729 |
| 132 | MP0000647_abnormal_sebaceous_gland | 0.80992573 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.80657043 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.79932625 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.79646464 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.78479318 |
| 137 | MP0005451_abnormal_body_composition | 0.77665548 |
| 138 | MP0002067_abnormal_sensory_capabilities | 0.76701307 |
| 139 | MP0002132_abnormal_respiratory_system | 0.76430638 |
| 140 | MP0001440_abnormal_grooming_behavior | 0.74901766 |
| 141 | MP0001873_stomach_inflammation | 0.74412467 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.73955264 |
| 143 | MP0001502_abnormal_circadian_rhythm | 0.73049657 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.72310580 |
| 145 | MP0003279_aneurysm | 0.72035248 |
| 146 | MP0005379_endocrine/exocrine_gland_phen | 0.71452034 |
| 147 | MP0006082_CNS_inflammation | 0.71001842 |
| 148 | MP0000579_abnormal_nail_morphology | 0.70540727 |
| 149 | MP0003045_fibrosis | 0.68480928 |
| 150 | MP0000685_abnormal_immune_system | 0.67743236 |
| 151 | MP0001984_abnormal_olfaction | 0.66487548 |
| 152 | MP0000747_muscle_weakness | 0.66232776 |
| 153 | MP0002933_joint_inflammation | 0.65075186 |
| 154 | MP0005645_abnormal_hypothalamus_physiol | 0.64399080 |
| 155 | MP0002108_abnormal_muscle_morphology | 0.62603253 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.62577942 |
| 157 | MP0002405_respiratory_system_inflammati | 0.61441671 |
| 158 | MP0005646_abnormal_pituitary_gland | 0.61422333 |
| 159 | MP0006036_abnormal_mitochondrial_physio | 0.58982906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Calf muscle hypertrophy (HP:0008981) | 5.58640137 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.39148243 |
| 3 | Sudden death (HP:0001699) | 5.32337001 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.20695738 |
| 5 | Atrial fibrillation (HP:0005110) | 4.93456998 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.60972462 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 4.51636113 |
| 8 | Subaortic stenosis (HP:0001682) | 4.37736716 |
| 9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.37736716 |
| 10 | Supraventricular tachycardia (HP:0004755) | 4.29410670 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.16408545 |
| 12 | Supraventricular arrhythmia (HP:0005115) | 4.13355139 |
| 13 | Syncope (HP:0001279) | 3.87522724 |
| 14 | Pancreatic cysts (HP:0001737) | 3.86039121 |
| 15 | Lipoatrophy (HP:0100578) | 3.84100005 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.82341288 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 3.68800924 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.63086752 |
| 19 | True hermaphroditism (HP:0010459) | 3.62818427 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.58720721 |
| 21 | Type II lissencephaly (HP:0007260) | 3.58704722 |
| 22 | Prolonged QT interval (HP:0001657) | 3.53307034 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.46699181 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.46699181 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.41315578 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 3.31462947 |
| 27 | Pancreatic fibrosis (HP:0100732) | 3.27458397 |
| 28 | Nephronophthisis (HP:0000090) | 3.26402382 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.19734860 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.06017084 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.05777952 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.02986593 |
| 33 | Optic neuritis (HP:0100653) | 3.02986593 |
| 34 | Palpitations (HP:0001962) | 2.99502922 |
| 35 | Congenital, generalized hypertrichosis (HP:0004540) | 2.92140761 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.91996759 |
| 37 | Myoglobinuria (HP:0002913) | 2.87902524 |
| 38 | Left ventricular hypertrophy (HP:0001712) | 2.87539745 |
| 39 | Furrowed tongue (HP:0000221) | 2.85952062 |
| 40 | Inability to walk (HP:0002540) | 2.85837977 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 2.83641016 |
| 42 | Bundle branch block (HP:0011710) | 2.83626685 |
| 43 | Heart block (HP:0012722) | 2.81533220 |
| 44 | Concave nail (HP:0001598) | 2.75701369 |
| 45 | Abnormal EKG (HP:0003115) | 2.68479563 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.64682730 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.61818703 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.60895475 |
| 49 | Renal cortical cysts (HP:0000803) | 2.60693441 |
| 50 | Hyperventilation (HP:0002883) | 2.60321109 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.58582278 |
| 52 | Tubular atrophy (HP:0000092) | 2.54451457 |
| 53 | Ventricular arrhythmia (HP:0004308) | 2.52597480 |
| 54 | Chromsome breakage (HP:0040012) | 2.48865728 |
| 55 | Pulmonary artery stenosis (HP:0004415) | 2.42254468 |
| 56 | Orchitis (HP:0100796) | 2.41407958 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.41366410 |
| 58 | Severe muscular hypotonia (HP:0006829) | 2.39391297 |
| 59 | Cystic liver disease (HP:0006706) | 2.38181696 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.38068875 |
| 61 | Congenital hepatic fibrosis (HP:0002612) | 2.37983998 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.37287022 |
| 63 | Increased connective tissue (HP:0009025) | 2.37092326 |
| 64 | Polydipsia (HP:0001959) | 2.33320877 |
| 65 | Abnormal drinking behavior (HP:0030082) | 2.33320877 |
| 66 | Pendular nystagmus (HP:0012043) | 2.28706698 |
| 67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.27817782 |
| 68 | Duplicated collecting system (HP:0000081) | 2.27342996 |
| 69 | Acute necrotizing encephalopathy (HP:0006965) | 2.25122581 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.24546814 |
| 71 | Muscle fiber inclusion bodies (HP:0100299) | 2.24423271 |
| 72 | Atrioventricular block (HP:0001678) | 2.23401437 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21844909 |
| 74 | Cerebellar dysplasia (HP:0007033) | 2.21564349 |
| 75 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.20593483 |
| 76 | Aplasia cutis congenita (HP:0001057) | 2.18333213 |
| 77 | Abnormality of the renal collecting system (HP:0004742) | 2.16185919 |
| 78 | Optic disc pallor (HP:0000543) | 2.15958019 |
| 79 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15017369 |
| 80 | Gingivitis (HP:0000230) | 2.13982093 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.13561273 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 2.13163140 |
| 83 | Rhabdomyolysis (HP:0003201) | 2.13152584 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10491539 |
| 85 | Myotonia (HP:0002486) | 2.10310257 |
| 86 | Type 1 muscle fiber predominance (HP:0003803) | 2.10286930 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 2.09196615 |
| 88 | Hyperalaninemia (HP:0003348) | 2.09196615 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09196615 |
| 90 | Erythroderma (HP:0001019) | 2.07787069 |
| 91 | Sclerocornea (HP:0000647) | 2.07351404 |
| 92 | Abnormality of secondary sexual hair (HP:0009888) | 2.05732006 |
| 93 | Abnormality of the axillary hair (HP:0100134) | 2.05732006 |
| 94 | Decreased central vision (HP:0007663) | 2.02363428 |
| 95 | Conjunctival hamartoma (HP:0100780) | 2.02352377 |
| 96 | Hepatic necrosis (HP:0002605) | 2.02015959 |
| 97 | Rimmed vacuoles (HP:0003805) | 2.01155475 |
| 98 | Myositis (HP:0100614) | 2.01089733 |
| 99 | Lissencephaly (HP:0001339) | 2.00945846 |
| 100 | Palmoplantar keratoderma (HP:0000982) | 2.00628752 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.98770695 |
| 102 | Limb dystonia (HP:0002451) | 1.98118158 |
| 103 | Clumsiness (HP:0002312) | 1.97413653 |
| 104 | Basal ganglia calcification (HP:0002135) | 1.96180151 |
| 105 | Prostate neoplasm (HP:0100787) | 1.95199018 |
| 106 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94619804 |
| 107 | Mitochondrial inheritance (HP:0001427) | 1.93748172 |
| 108 | Acute encephalopathy (HP:0006846) | 1.91380055 |
| 109 | Abnormality of the endocardium (HP:0004306) | 1.91270808 |
| 110 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91100788 |
| 111 | Anencephaly (HP:0002323) | 1.90666512 |
| 112 | Febrile seizures (HP:0002373) | 1.90360660 |
| 113 | Abnormal biliary tract physiology (HP:0012439) | 1.90105620 |
| 114 | Bile duct proliferation (HP:0001408) | 1.90105620 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.89892540 |
| 116 | Hypothermia (HP:0002045) | 1.89677300 |
| 117 | Retinal dysplasia (HP:0007973) | 1.89654146 |
| 118 | Hyperkalemia (HP:0002153) | 1.89176585 |
| 119 | Keratoconus (HP:0000563) | 1.88216099 |
| 120 | Increased corneal curvature (HP:0100692) | 1.88216099 |
| 121 | Lip pit (HP:0100267) | 1.88112600 |
| 122 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.87700139 |
| 123 | Exercise intolerance (HP:0003546) | 1.86964811 |
| 124 | Distal arthrogryposis (HP:0005684) | 1.86395073 |
| 125 | Cerebral palsy (HP:0100021) | 1.85690713 |
| 126 | Weak cry (HP:0001612) | 1.85494164 |
| 127 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85275612 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.85236325 |
| 129 | Testicular atrophy (HP:0000029) | 1.85231283 |
| 130 | Abnormality of the right ventricle (HP:0001707) | 1.85196078 |
| 131 | Bilateral microphthalmos (HP:0007633) | 1.82331732 |
| 132 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.81805530 |
| 133 | Exertional dyspnea (HP:0002875) | 1.81477973 |
| 134 | Abnormality of the neuromuscular junction (HP:0003398) | 1.80721694 |
| 135 | Fatigable weakness (HP:0003473) | 1.80721694 |
| 136 | Nemaline bodies (HP:0003798) | 1.79806892 |
| 137 | Keratoconjunctivitis (HP:0001096) | 1.79444296 |
| 138 | Osteomalacia (HP:0002749) | 1.79343876 |
| 139 | Large for gestational age (HP:0001520) | 1.79182639 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.79118375 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.79118375 |
| 142 | Male pseudohermaphroditism (HP:0000037) | 1.78765138 |
| 143 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.78651372 |
| 144 | Hypoplasia of the fovea (HP:0007750) | 1.78651372 |
| 145 | Polyuria (HP:0000103) | 1.77955149 |
| 146 | Progressive inability to walk (HP:0002505) | 1.77776789 |
| 147 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77077336 |
| 148 | Bradycardia (HP:0001662) | 1.76851862 |
| 149 | Difficulty running (HP:0009046) | 1.76622189 |
| 150 | Ketosis (HP:0001946) | 1.76475201 |
| 151 | Progressive macrocephaly (HP:0004481) | 1.76468558 |
| 152 | White forelock (HP:0002211) | 1.76107182 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.75427263 |
| 154 | Hypoplastic left heart (HP:0004383) | 1.73526919 |
| 155 | Patchy hypopigmentation of hair (HP:0011365) | 1.73415061 |
| 156 | Hemiparesis (HP:0001269) | 1.73242849 |
| 157 | Malignant hyperthermia (HP:0002047) | 1.72780335 |
| 158 | Neck muscle weakness (HP:0000467) | 1.72158961 |
| 159 | Renal Fanconi syndrome (HP:0001994) | 1.72037635 |
| 160 | Oligomenorrhea (HP:0000876) | 1.71124541 |
| 161 | Optic nerve hypoplasia (HP:0000609) | 1.70826002 |
| 162 | Abnormality of the pons (HP:0007361) | 1.70034282 |
| 163 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69939002 |
| 164 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69939002 |
| 165 | Abnormal finger flexion creases (HP:0006143) | 1.69803416 |
| 166 | Absent phalangeal crease (HP:0006109) | 1.69742919 |
| 167 | Hepatocellular necrosis (HP:0001404) | 1.69402377 |
| 168 | Progressive cerebellar ataxia (HP:0002073) | 1.69182137 |
| 169 | Generalized aminoaciduria (HP:0002909) | 1.67585459 |
| 170 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67454868 |
| 171 | Chronic hepatic failure (HP:0100626) | 1.67308103 |
| 172 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.66052530 |
| 173 | Recurrent fungal infections (HP:0002841) | 1.65972840 |
| 174 | Increased CSF lactate (HP:0002490) | 1.65330952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.77217900 |
| 2 | IRAK3 | 3.67864549 |
| 3 | ACVR1B | 3.34458801 |
| 4 | ZAK | 3.05454652 |
| 5 | MAP3K14 | 2.98268607 |
| 6 | OBSCN | 2.85633696 |
| 7 | TTN | 2.63737137 |
| 8 | INSRR | 2.63184242 |
| 9 | IRAK4 | 2.58331924 |
| 10 | GRK7 | 2.45859895 |
| 11 | PHKG1 | 2.42421459 |
| 12 | PHKG2 | 2.42421459 |
| 13 | TXK | 2.34043645 |
| 14 | TLK1 | 2.23134616 |
| 15 | WNK3 | 2.16347310 |
| 16 | BLK | 2.09039328 |
| 17 | CASK | 2.07287103 |
| 18 | MUSK | 1.94736002 |
| 19 | MARK1 | 1.81360360 |
| 20 | PINK1 | 1.80194988 |
| 21 | STK24 | 1.80057668 |
| 22 | PIK3CA | 1.78590974 |
| 23 | MYLK | 1.77498975 |
| 24 | TGFBR1 | 1.75015344 |
| 25 | MAP4K2 | 1.74426858 |
| 26 | EPHA3 | 1.72826340 |
| 27 | LMTK2 | 1.70444569 |
| 28 | TGFBR2 | 1.64734411 |
| 29 | OXSR1 | 1.61676499 |
| 30 | WNK4 | 1.60286660 |
| 31 | EIF2AK2 | 1.58744358 |
| 32 | IRAK1 | 1.57238181 |
| 33 | DMPK | 1.45821973 |
| 34 | ADRBK1 | 1.45110304 |
| 35 | DAPK2 | 1.40066007 |
| 36 | IKBKB | 1.35741937 |
| 37 | PKN1 | 1.34830021 |
| 38 | SIK3 | 1.33112953 |
| 39 | IKBKE | 1.27443576 |
| 40 | SGK2 | 1.26167589 |
| 41 | JAK1 | 1.25834382 |
| 42 | DYRK2 | 1.24487646 |
| 43 | STK39 | 1.20444038 |
| 44 | BMPR2 | 1.20354109 |
| 45 | MAPKAPK3 | 1.13997852 |
| 46 | TNIK | 1.12985417 |
| 47 | YES1 | 1.12313062 |
| 48 | NLK | 1.10489616 |
| 49 | PNCK | 1.09615262 |
| 50 | JAK3 | 1.06378962 |
| 51 | IRAK2 | 1.06246133 |
| 52 | STK38L | 1.02889853 |
| 53 | TYK2 | 1.02547607 |
| 54 | AKT3 | 1.01588729 |
| 55 | TIE1 | 1.00852565 |
| 56 | CHUK | 1.00830066 |
| 57 | TBK1 | 1.00603761 |
| 58 | TAF1 | 1.00145661 |
| 59 | NEK9 | 0.95432574 |
| 60 | ADRBK2 | 0.94325152 |
| 61 | TRPM7 | 0.94250960 |
| 62 | PIK3CG | 0.93259715 |
| 63 | NUAK1 | 0.91640976 |
| 64 | MAPK12 | 0.89265435 |
| 65 | PRKAA2 | 0.89176940 |
| 66 | PRKCE | 0.87204591 |
| 67 | MAP3K12 | 0.86805006 |
| 68 | MKNK2 | 0.85906312 |
| 69 | STK4 | 0.84703951 |
| 70 | BMPR1B | 0.83755870 |
| 71 | MAP3K4 | 0.83485915 |
| 72 | MAP2K3 | 0.83015211 |
| 73 | MAPK15 | 0.82097068 |
| 74 | TAOK3 | 0.81914476 |
| 75 | KIT | 0.79396610 |
| 76 | CAMK4 | 0.78389333 |
| 77 | MAPK7 | 0.78033570 |
| 78 | CDK3 | 0.77475071 |
| 79 | TAOK2 | 0.76669185 |
| 80 | TEC | 0.76588615 |
| 81 | NME1 | 0.76453362 |
| 82 | MAP2K4 | 0.76418802 |
| 83 | MAP2K6 | 0.75704097 |
| 84 | PRKCG | 0.73900624 |
| 85 | VRK1 | 0.70317637 |
| 86 | PDK2 | 0.69311018 |
| 87 | CAMK2D | 0.68970974 |
| 88 | MAP3K11 | 0.67725920 |
| 89 | MAP4K1 | 0.67579661 |
| 90 | EPHB2 | 0.67363364 |
| 91 | PAK3 | 0.67156816 |
| 92 | SGK3 | 0.66659410 |
| 93 | CAMK2A | 0.64791250 |
| 94 | GRK1 | 0.64523865 |
| 95 | PLK4 | 0.63708426 |
| 96 | RPS6KA6 | 0.63412748 |
| 97 | CDC42BPA | 0.62853897 |
| 98 | RPS6KL1 | 0.62639137 |
| 99 | RPS6KC1 | 0.62639137 |
| 100 | ERBB3 | 0.62535291 |
| 101 | NEK6 | 0.61727966 |
| 102 | SYK | 0.60206971 |
| 103 | MAP3K5 | 0.59942615 |
| 104 | FER | 0.59692972 |
| 105 | CDK8 | 0.56703992 |
| 106 | MAP2K7 | 0.55919525 |
| 107 | PRKAA1 | 0.52213835 |
| 108 | PRKCI | 0.51465512 |
| 109 | PDK4 | 0.49636120 |
| 110 | PDK3 | 0.49636120 |
| 111 | BTK | 0.49162511 |
| 112 | CDK19 | 0.47420196 |
| 113 | MAPK13 | 0.45241317 |
| 114 | MAP2K2 | 0.45025636 |
| 115 | SGK494 | 0.44539654 |
| 116 | SGK223 | 0.44539654 |
| 117 | PRKCZ | 0.44502622 |
| 118 | HCK | 0.43710679 |
| 119 | PRKD1 | 0.43679410 |
| 120 | SIK1 | 0.42648002 |
| 121 | RPS6KA5 | 0.42105993 |
| 122 | EPHB1 | 0.41728592 |
| 123 | MAP3K3 | 0.41377228 |
| 124 | FGFR3 | 0.41176718 |
| 125 | PRKCD | 0.40792345 |
| 126 | PRKG1 | 0.40496208 |
| 127 | SGK1 | 0.40260129 |
| 128 | CSNK1A1 | 0.39877961 |
| 129 | CSNK1G1 | 0.39708548 |
| 130 | MAP2K1 | 0.39369472 |
| 131 | PRKACA | 0.39323759 |
| 132 | MATK | 0.39121992 |
| 133 | CSNK1G2 | 0.38853818 |
| 134 | STK16 | 0.38150569 |
| 135 | STK11 | 0.38016015 |
| 136 | CAMK1D | 0.37647004 |
| 137 | MAPKAPK2 | 0.37587345 |
| 138 | FLT3 | 0.36760399 |
| 139 | LYN | 0.35996782 |
| 140 | BCKDK | 0.35926657 |
| 141 | MAPKAPK5 | 0.34448709 |
| 142 | MAP3K9 | 0.33133395 |
| 143 | RPS6KB1 | 0.32117885 |
| 144 | MAP3K7 | 0.30855187 |
| 145 | PRKCQ | 0.30638346 |
| 146 | FGFR2 | 0.30348627 |
| 147 | MST4 | 0.28918224 |
| 148 | DYRK3 | 0.28059224 |
| 149 | GRK6 | 0.27916438 |
| 150 | MAPK4 | 0.27207137 |
| 151 | PTK2B | 0.26525577 |
| 152 | WEE1 | 0.26424653 |
| 153 | CAMKK2 | 0.25915255 |
| 154 | PRKACB | 0.25666427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.33657262 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.08792399 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.86752865 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80377141 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.77279566 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63095657 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.40192674 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32981624 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30534295 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.24963888 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04823145 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.02888165 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98761626 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.96316348 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.87384563 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87143888 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85505396 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82506793 |
| 19 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.81919973 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.77876323 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.77465699 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.75315842 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72846425 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71824275 |
| 25 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69195357 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66799634 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64634804 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64081651 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.62965685 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62659746 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.62624415 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.62369603 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62289173 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51030775 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49064948 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47488197 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46366262 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43289388 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.41415232 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36619641 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33325419 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33231800 |
| 43 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33223002 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33090472 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31143743 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28614395 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21817993 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.20982544 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20845788 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19279594 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19205065 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17428965 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17077363 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15577541 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13882231 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12104140 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12019402 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08310373 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06365029 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05481281 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05010154 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04145846 |
| 63 | RNA polymerase_Homo sapiens_hsa03020 | 1.01015414 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 1.00497206 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00090735 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.98324185 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.95926160 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95565610 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93240391 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.89371860 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89266700 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89234476 |
| 73 | Ribosome_Homo sapiens_hsa03010 | 0.88690372 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87454082 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86824012 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86366534 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86111210 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85010793 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84799067 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83732533 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82556071 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80751515 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76824547 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76181732 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.75883712 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.74684538 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74338029 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74110234 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72440748 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72316144 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71894183 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71190180 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.68497753 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68205373 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68086183 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.67728481 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66941746 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66174120 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.65809091 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.65791629 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65594639 |
| 102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64749468 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.64209317 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60713625 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60674645 |
| 106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60615073 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.59747872 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57983915 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57806189 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.56462198 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.56321224 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55037715 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55032706 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54110551 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53557431 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52334914 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52184539 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51732621 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51218396 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51071292 |
| 121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50979304 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50954942 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50288783 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49883920 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49375102 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.47982069 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45987892 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45643787 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45555055 |
| 130 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44710011 |
| 131 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44560663 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44403800 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44250602 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44241234 |
| 135 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43806892 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.43152718 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43052321 |
| 138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42443632 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42412020 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42305938 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.42257902 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.40519658 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.40359817 |
| 144 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40334683 |
| 145 | Homologous recombination_Homo sapiens_hsa03440 | 0.40281916 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39883748 |
| 147 | Salivary secretion_Homo sapiens_hsa04970 | 0.39583148 |
| 148 | Purine metabolism_Homo sapiens_hsa00230 | 0.39190791 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38173372 |
| 150 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35173084 |
| 151 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34594288 |
| 152 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34334458 |
| 153 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33349209 |
| 154 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33229708 |
| 155 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32962071 |

